2025 Q4 -tulosraportti
Vain PDF
24 päivää sitten
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 210 | - | - | ||
| 608 | - | - | ||
| 1 000 | - | - | ||
| 2 100 | - | - | ||
| 31 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·11 min sittenIf the chatgpt gang here succeeds in helping to drive up the share price enough towards Friday, and VWAP becomes 10 kr and the price crashes afterwards, then a new directed issue is guaranteed, they want to get that money in. The only thing that speaks against this fantastic company is the ownership base. Calm down, it is after Friday that things can happen, and most importantly of all: Things Take Time
·1 t sittenThe Accountant's Guide to the "Quiet" Friday and the Great Torment It's Saturday evening. While normal people watch Netflix, we sit here meticulously counting decimals. Friday was described as "quiet", which in biotech-speak means we swung by a mere 10 % between top and bottom. Just a completely normal day at the office for those with nerves of steel and a calculator in their pocket. 1. Autopsy of Day 1 (The Official Figures) We have now completed the first of ten trading days that determine the subscription price. Here is the result from Oslo Børs for Friday, May 8: Today's High: 9.63 kr Today's Low: 8.71 kr Exact VWAP (Average): 9.3122 kr 2. The Warrant Math (Our "Safety Rope") The calculation that gives us sleep at night (for now): Average Price (VWAP): 9.3122 kr Minus 20 % discount: 7.44976 kr Entry Price (CRNAS average price): 0.5230 kr TOTAL COST PRICE: 7.97276 kr 3. The Great Torment: Exact Times Remember that Boston is 6 hours behind us. When things happen over there, we are often on our way into evening coziness – or the nightmare. Calendar for the Lost (Norwegian time): Monday, May 11 & Tuesday, May 12: "The Danger Zone". A stock exchange announcement can "pop" at any time between 08:00 and 22:00. Wednesday, May 13 at 18:00 – 20:00: Poster Presentation (Circular RNA / 40-fold increase in the heart). Expect leaks in social media here. Thursday, May 14: Ascension Day (STOCK EXCHANGE CLOSED). We are locked out while the USA digests the figures. The ultimate torture. Friday, May 15 at 22:15: Oral Presentation (The CircVec platform). Happens after Oslo has gone for the weekend; we sit with the result in our stomach until Monday morning. 4. Strategic Analysis: Two Roads to Boston The Direct Buyers (Closing price 9.52 kr): You have bought freedom. You can sell in a second Monday morning if the data explodes. You pay for liquidity. Warrant Crowd (7.97 kr): We have chosen the discount menu. With a buffer of almost 1.55 kr, we sit safely in our padded cell if the market panics on Monday or Tuesday. The Cynic's Corner: We never know when NewsWeb pings. It can happen at 08:00 Monday before the coffee is ready, or in the middle of the oral presentation on Friday. With the time difference, we are doomed to be the last to trade on the news, but with 7.97 kr as a base, we have at least done our homework. We have 9 trading days left before the final warrant price is ready. Keep the calculator charged and NewsWeb open! Important: Read up on the facts yourself and make your own assessments before any buying and selling. This stock swings faster than your grandma can put in her dentures when Sunday dinner is served!
·5 t sitten@adrianstrom1 tells that the price will go up towards 50kr·1 t sitten · MuokattuIf circVec actually delivers longer and stronger expression with a lower dose, it is not only relevant for gene therapy — but also next-generation RNA vaccines, including viruses like hantavirus The market still prices Circio as a niche case. That could be a grave mistake
·1 t sittenIT'S SATURDAY. THE STOCK MARKET IS CLOSED. BUT THE GAME IS ON. ♟️ While most people spend the weekend stressing over red figures or checking if their index fund moved 0.1 % on Friday… Right now, the Circio-team is getting ready for Boston. Destination: ASGCT. 🇺🇸🧬 They are not traveling there to mingle and drink coffee. They are traveling there with data. In vivo-data. AAV-data. Eye. Heart. CNS. 60x expression. 22x higher output at 10x lower dose. A message that the gene therapy community actually understands: More effect per biological input. Lower dose. Better safety-margin. Potential solution to one of the biggest bottlenecks in gene therapy. And in the background lies the rest of the stack: Acuitas. LNP. In vivo CAR-T. TraffikGene. Non-viral delivery. Partner-funded in vivo-testing. This is not a regular conference. This is the place where technology meets the field. Where people who actually understand AAV, dose, delivery, expression and safety can see what circVec is trying to solve. Our job is simple now. We have read the data. We have understood the asymmetry. We have taken the risk before everything is fully proven. Now it's the company's turn to take the stage. Boston awaits. The market is closed. But the game is on. Log off. Enjoy Saturday. Next week the show starts. We know what we own. ♟️🧱🍷
·11 t sittenIT'S SATURDAY. THE STOCK MARKET IS CLOSED. BUT THE GAME IS ON. ♟️ While most people spend the weekend stressing over red figures or checking if their index fund moved 0.1 % on Friday… Right now, the Circio-team is getting ready for Boston. Destination: ASGCT. 🇺🇸🧬 They are not traveling there to mingle and drink coffee. They are traveling there with data. In vivo-data. AAV-data. Eye. Heart. CNS. 60x expression. 22x higher output at 10x lower dose. A message that the gene therapy community actually understands: More effect per biological input. Lower dose. Better safety-margin. Potential solution to one of the biggest bottlenecks in gene therapy. And in the background lies the rest of the stack: Acuitas. LNP. In vivo CAR-T. TraffikGene. Non-viral delivery. Partner-funded in vivo-testing. This is not a regular conference. This is the place where technology meets the field. Where people who actually understand AAV, dose, delivery, expression and safety can see what circVec is trying to solve. Our job is simple now. We have read the data. We have understood the asymmetry. We have taken the risk before everything is fully proven. Now it's the company's turn to take the stage. Boston awaits. The market is closed. But the game is on. Log off. Enjoy Saturday. Next week the show starts. We know what we own. ♟️🧱🍷
17 t sitten17 t sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
24 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·11 min sittenIf the chatgpt gang here succeeds in helping to drive up the share price enough towards Friday, and VWAP becomes 10 kr and the price crashes afterwards, then a new directed issue is guaranteed, they want to get that money in. The only thing that speaks against this fantastic company is the ownership base. Calm down, it is after Friday that things can happen, and most importantly of all: Things Take Time
- ·1 t sittenThe Accountant's Guide to the "Quiet" Friday and the Great Torment It's Saturday evening. While normal people watch Netflix, we sit here meticulously counting decimals. Friday was described as "quiet", which in biotech-speak means we swung by a mere 10 % between top and bottom. Just a completely normal day at the office for those with nerves of steel and a calculator in their pocket. 1. Autopsy of Day 1 (The Official Figures) We have now completed the first of ten trading days that determine the subscription price. Here is the result from Oslo Børs for Friday, May 8: Today's High: 9.63 kr Today's Low: 8.71 kr Exact VWAP (Average): 9.3122 kr 2. The Warrant Math (Our "Safety Rope") The calculation that gives us sleep at night (for now): Average Price (VWAP): 9.3122 kr Minus 20 % discount: 7.44976 kr Entry Price (CRNAS average price): 0.5230 kr TOTAL COST PRICE: 7.97276 kr 3. The Great Torment: Exact Times Remember that Boston is 6 hours behind us. When things happen over there, we are often on our way into evening coziness – or the nightmare. Calendar for the Lost (Norwegian time): Monday, May 11 & Tuesday, May 12: "The Danger Zone". A stock exchange announcement can "pop" at any time between 08:00 and 22:00. Wednesday, May 13 at 18:00 – 20:00: Poster Presentation (Circular RNA / 40-fold increase in the heart). Expect leaks in social media here. Thursday, May 14: Ascension Day (STOCK EXCHANGE CLOSED). We are locked out while the USA digests the figures. The ultimate torture. Friday, May 15 at 22:15: Oral Presentation (The CircVec platform). Happens after Oslo has gone for the weekend; we sit with the result in our stomach until Monday morning. 4. Strategic Analysis: Two Roads to Boston The Direct Buyers (Closing price 9.52 kr): You have bought freedom. You can sell in a second Monday morning if the data explodes. You pay for liquidity. Warrant Crowd (7.97 kr): We have chosen the discount menu. With a buffer of almost 1.55 kr, we sit safely in our padded cell if the market panics on Monday or Tuesday. The Cynic's Corner: We never know when NewsWeb pings. It can happen at 08:00 Monday before the coffee is ready, or in the middle of the oral presentation on Friday. With the time difference, we are doomed to be the last to trade on the news, but with 7.97 kr as a base, we have at least done our homework. We have 9 trading days left before the final warrant price is ready. Keep the calculator charged and NewsWeb open! Important: Read up on the facts yourself and make your own assessments before any buying and selling. This stock swings faster than your grandma can put in her dentures when Sunday dinner is served!
- ·5 t sitten@adrianstrom1 tells that the price will go up towards 50kr·1 t sitten · MuokattuIf circVec actually delivers longer and stronger expression with a lower dose, it is not only relevant for gene therapy — but also next-generation RNA vaccines, including viruses like hantavirus The market still prices Circio as a niche case. That could be a grave mistake·1 t sittenIT'S SATURDAY. THE STOCK MARKET IS CLOSED. BUT THE GAME IS ON. ♟️ While most people spend the weekend stressing over red figures or checking if their index fund moved 0.1 % on Friday… Right now, the Circio-team is getting ready for Boston. Destination: ASGCT. 🇺🇸🧬 They are not traveling there to mingle and drink coffee. They are traveling there with data. In vivo-data. AAV-data. Eye. Heart. CNS. 60x expression. 22x higher output at 10x lower dose. A message that the gene therapy community actually understands: More effect per biological input. Lower dose. Better safety-margin. Potential solution to one of the biggest bottlenecks in gene therapy. And in the background lies the rest of the stack: Acuitas. LNP. In vivo CAR-T. TraffikGene. Non-viral delivery. Partner-funded in vivo-testing. This is not a regular conference. This is the place where technology meets the field. Where people who actually understand AAV, dose, delivery, expression and safety can see what circVec is trying to solve. Our job is simple now. We have read the data. We have understood the asymmetry. We have taken the risk before everything is fully proven. Now it's the company's turn to take the stage. Boston awaits. The market is closed. But the game is on. Log off. Enjoy Saturday. Next week the show starts. We know what we own. ♟️🧱🍷
- ·11 t sittenIT'S SATURDAY. THE STOCK MARKET IS CLOSED. BUT THE GAME IS ON. ♟️ While most people spend the weekend stressing over red figures or checking if their index fund moved 0.1 % on Friday… Right now, the Circio-team is getting ready for Boston. Destination: ASGCT. 🇺🇸🧬 They are not traveling there to mingle and drink coffee. They are traveling there with data. In vivo-data. AAV-data. Eye. Heart. CNS. 60x expression. 22x higher output at 10x lower dose. A message that the gene therapy community actually understands: More effect per biological input. Lower dose. Better safety-margin. Potential solution to one of the biggest bottlenecks in gene therapy. And in the background lies the rest of the stack: Acuitas. LNP. In vivo CAR-T. TraffikGene. Non-viral delivery. Partner-funded in vivo-testing. This is not a regular conference. This is the place where technology meets the field. Where people who actually understand AAV, dose, delivery, expression and safety can see what circVec is trying to solve. Our job is simple now. We have read the data. We have understood the asymmetry. We have taken the risk before everything is fully proven. Now it's the company's turn to take the stage. Boston awaits. The market is closed. But the game is on. Log off. Enjoy Saturday. Next week the show starts. We know what we own. ♟️🧱🍷
- 17 t sitten17 t sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 210 | - | - | ||
| 608 | - | - | ||
| 1 000 | - | - | ||
| 2 100 | - | - | ||
| 31 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
2025 Q4 -tulosraportti
Vain PDF
24 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·11 min sittenIf the chatgpt gang here succeeds in helping to drive up the share price enough towards Friday, and VWAP becomes 10 kr and the price crashes afterwards, then a new directed issue is guaranteed, they want to get that money in. The only thing that speaks against this fantastic company is the ownership base. Calm down, it is after Friday that things can happen, and most importantly of all: Things Take Time
- ·1 t sittenThe Accountant's Guide to the "Quiet" Friday and the Great Torment It's Saturday evening. While normal people watch Netflix, we sit here meticulously counting decimals. Friday was described as "quiet", which in biotech-speak means we swung by a mere 10 % between top and bottom. Just a completely normal day at the office for those with nerves of steel and a calculator in their pocket. 1. Autopsy of Day 1 (The Official Figures) We have now completed the first of ten trading days that determine the subscription price. Here is the result from Oslo Børs for Friday, May 8: Today's High: 9.63 kr Today's Low: 8.71 kr Exact VWAP (Average): 9.3122 kr 2. The Warrant Math (Our "Safety Rope") The calculation that gives us sleep at night (for now): Average Price (VWAP): 9.3122 kr Minus 20 % discount: 7.44976 kr Entry Price (CRNAS average price): 0.5230 kr TOTAL COST PRICE: 7.97276 kr 3. The Great Torment: Exact Times Remember that Boston is 6 hours behind us. When things happen over there, we are often on our way into evening coziness – or the nightmare. Calendar for the Lost (Norwegian time): Monday, May 11 & Tuesday, May 12: "The Danger Zone". A stock exchange announcement can "pop" at any time between 08:00 and 22:00. Wednesday, May 13 at 18:00 – 20:00: Poster Presentation (Circular RNA / 40-fold increase in the heart). Expect leaks in social media here. Thursday, May 14: Ascension Day (STOCK EXCHANGE CLOSED). We are locked out while the USA digests the figures. The ultimate torture. Friday, May 15 at 22:15: Oral Presentation (The CircVec platform). Happens after Oslo has gone for the weekend; we sit with the result in our stomach until Monday morning. 4. Strategic Analysis: Two Roads to Boston The Direct Buyers (Closing price 9.52 kr): You have bought freedom. You can sell in a second Monday morning if the data explodes. You pay for liquidity. Warrant Crowd (7.97 kr): We have chosen the discount menu. With a buffer of almost 1.55 kr, we sit safely in our padded cell if the market panics on Monday or Tuesday. The Cynic's Corner: We never know when NewsWeb pings. It can happen at 08:00 Monday before the coffee is ready, or in the middle of the oral presentation on Friday. With the time difference, we are doomed to be the last to trade on the news, but with 7.97 kr as a base, we have at least done our homework. We have 9 trading days left before the final warrant price is ready. Keep the calculator charged and NewsWeb open! Important: Read up on the facts yourself and make your own assessments before any buying and selling. This stock swings faster than your grandma can put in her dentures when Sunday dinner is served!
- ·5 t sitten@adrianstrom1 tells that the price will go up towards 50kr·1 t sitten · MuokattuIf circVec actually delivers longer and stronger expression with a lower dose, it is not only relevant for gene therapy — but also next-generation RNA vaccines, including viruses like hantavirus The market still prices Circio as a niche case. That could be a grave mistake·1 t sittenIT'S SATURDAY. THE STOCK MARKET IS CLOSED. BUT THE GAME IS ON. ♟️ While most people spend the weekend stressing over red figures or checking if their index fund moved 0.1 % on Friday… Right now, the Circio-team is getting ready for Boston. Destination: ASGCT. 🇺🇸🧬 They are not traveling there to mingle and drink coffee. They are traveling there with data. In vivo-data. AAV-data. Eye. Heart. CNS. 60x expression. 22x higher output at 10x lower dose. A message that the gene therapy community actually understands: More effect per biological input. Lower dose. Better safety-margin. Potential solution to one of the biggest bottlenecks in gene therapy. And in the background lies the rest of the stack: Acuitas. LNP. In vivo CAR-T. TraffikGene. Non-viral delivery. Partner-funded in vivo-testing. This is not a regular conference. This is the place where technology meets the field. Where people who actually understand AAV, dose, delivery, expression and safety can see what circVec is trying to solve. Our job is simple now. We have read the data. We have understood the asymmetry. We have taken the risk before everything is fully proven. Now it's the company's turn to take the stage. Boston awaits. The market is closed. But the game is on. Log off. Enjoy Saturday. Next week the show starts. We know what we own. ♟️🧱🍷
- ·11 t sittenIT'S SATURDAY. THE STOCK MARKET IS CLOSED. BUT THE GAME IS ON. ♟️ While most people spend the weekend stressing over red figures or checking if their index fund moved 0.1 % on Friday… Right now, the Circio-team is getting ready for Boston. Destination: ASGCT. 🇺🇸🧬 They are not traveling there to mingle and drink coffee. They are traveling there with data. In vivo-data. AAV-data. Eye. Heart. CNS. 60x expression. 22x higher output at 10x lower dose. A message that the gene therapy community actually understands: More effect per biological input. Lower dose. Better safety-margin. Potential solution to one of the biggest bottlenecks in gene therapy. And in the background lies the rest of the stack: Acuitas. LNP. In vivo CAR-T. TraffikGene. Non-viral delivery. Partner-funded in vivo-testing. This is not a regular conference. This is the place where technology meets the field. Where people who actually understand AAV, dose, delivery, expression and safety can see what circVec is trying to solve. Our job is simple now. We have read the data. We have understood the asymmetry. We have taken the risk before everything is fully proven. Now it's the company's turn to take the stage. Boston awaits. The market is closed. But the game is on. Log off. Enjoy Saturday. Next week the show starts. We know what we own. ♟️🧱🍷
- 17 t sitten17 t sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 210 | - | - | ||
| 608 | - | - | ||
| 1 000 | - | - | ||
| 2 100 | - | - | ||
| 31 | - | - |
Välittäjätilasto
Dataa ei löytynyt